Nurse practitioner (NP) led care: Cervical screening practices and experiences of women attending a women’s health centre

Abstract

BackgroundCervical cancer is the second most prevalent carcinoma among women. Stringent screening is the most effective strategy of reducing the morbidity and mortality associated with cervical cancer, however barriers to such screening exist. South West Sydney is primarily populated by ethnic minority groups and those with lower socioeconomic status. Thus, women from this area of Sydney represent some of the most disadvantaged women and face many barriers when accessing healthcare, including cervical cancer screening. Previous research has found that gender can influence attitudes and practices regarding women’s health screening. While women’s health nurse practitioners are becoming more involved in preventative healthcare including cervical cancer screening, the experiences of women who access their services have not been explored. AimThe aim of this study was to determine the demographic characteristics of the women accessing the Liverpool Women’s Health Centre and to explore their experiences of the service. MethodsDemographic data were collected over a one-year period and reflected the diversity of the women who access the WHC in the Liverpool local government area. Ten women who were first time users of the service, aged over the age of 18 years and fluent in English language were then interviewed to explore in-depth their experiences of service. FindingsStudy findings illustrated the benefits of providing free women-centred care. In addition to being accessible in terms of location and cost, women conveyed their appreciation for the continuity of care provided. Further, women who accessed the service reported the nurse practitioner provided a professional environment that facilitated the development of trust. ConclusionProviding a service that is accessible and comforting can increase the participation of vulnerable women in routine cervical cancer screening practices as well as reduce the morbidity and mortality rate of cervical cancer that often results from under-screening.